Artemis Medicare Services Limited
All news and filings related to Artemis Medicare Services Limited.
View all news & filings- Medium impact
Artemis Medicare Receives Show Cause Notice for ₹11.11 Crore Tax Dispute
Artemis Medicare Services Limited received a Show Cause Notice from CGST, Gurugram, for ₹11.11 Crore related to the financial year 2022-23. The notice concerns alleged non-remittance of GST charged on medicines and consumables. The company plans to file a writ petition, connecting it to a previous case where a stay was granted.
Read the summary - Medium impact
Artemis Medicare Services Receives ₹11.11 Cr GST Show Cause Notice
Artemis Medicare Services Limited received a Show Cause Notice from CGST, Gurugram, for FY 2022-23. The notice alleges non-remittance of GST charged on medicines and consumables to the government, with potential implications of ₹11.11 Crore plus interest and penalty. The company plans to file a writ petition to contest this.
Read the summary - Low impact
Artemis Medicare Services: Trading Window Closed from Oct 1, 2026 for Q2 FY27 Results
Artemis Medicare Services Limited will close its trading window from October 1, 2026. The window will reopen 48 hours after the declaration of financial results for the quarter ending September 30, 2026. This is in compliance with SEBI regulations.
Read the summary - Medium impact
Artemis Medicare reaffirms CARE A; Stable rating for ₹343.15 Cr bank facilities
Artemis Medicare Services Limited's long-term bank facilities of ₹343.15 crore have been reaffirmed with a CARE A; Stable rating. Long-term/short-term facilities of ₹45.00 crore also reaffirmed. Ratings based on FY26 audited and Q1FY27 unaudited performance.
Read the summary - Low impact
Artemis Medicare Services Announces Special Window for Physical Securities
Artemis Medicare Services Limited has opened a Special Window for the transfer and dematerialisation of physical securities. A public notice regarding this was published on September 15, 2026, in The Financial Express and The Jansatta.
Read the summary - Low impact
Artemis Medicare Services to Participate in Anand Rathi Conference on Sep 22
Artemis Medicare Services Limited will participate in the Anand Rathi Annual Flagship Conference G-200 Summit 2026 in Mumbai on September 22, 2026. Company representatives will engage in investor interactions during this physical event.
Read the summary - Low impact
Artemis Medicare Services to Participate in PhillipCapital Investor Conference on Sep 3
Artemis Medicare Services Limited representatives will participate in PhillipCapital's 'Market Marvel | Investing Beyond the Headlines' event. The conference is scheduled for September 3, 2026, in Delhi. This is a routine investor relations activity.
Read the summary - High impact
Artemis Medicare Q1 FY27 Revenue Up 12.7% to ₹287 Cr; Raipur Hospital Operational
Artemis Medicare reported Q1 FY27 consolidated revenue of ₹287.32 crore, up 12.7% YoY. EBITDA was ₹61.82 crore with a 21.5% margin. PAT grew 48.3% to ₹31.44 crore. The new Artemis Shanti Hospital in Raipur commenced operations. Plans include adding over 200 beds at Gurugram's Tower IV, aiming for 2,000 beds by 2029-30.
Read the summary - Low impact
Artemis Medicare Services to Participate in EMKAY Confluence 2026 Investor Conference
Artemis Medicare Services Limited will participate in the EMKAY Confluence 2026 Annual Investor Conference in Mumbai on August 13, 2026. The event will be held physically, allowing company representatives to interact with analysts and institutional investors.
Read the summary - Low impact
Artemis Medicare Services Q1 FY27 Earnings Conference Call Audio Recording Available
Artemis Medicare Services Limited has released the audio recording of its Q1 FY27 earnings conference call held on August 4, 2026. The call covered the company's operational and financial performance for the quarter.
Read the summary - Low impact
Artemis Medicare Services Publishes Q1 FY27 Un-audited Financial Results
Artemis Medicare Services Limited published its un-audited financial results for the quarter ended June 30, 2026. The results were published on August 4, 2026, in The Financial Express and The Jansatta. The results are also available on the company's investor website.
Read the summary - Low impact
Artemis Medicare Services: Monitoring Agency Report for Q1FY27 Released
Artemis Medicare Services Limited's Monitoring Agency Report for Q1FY27 shows utilization of ₹17.45 crore from its ₹330 crore preferential issue. Funds were used for medical equipment and hospital construction. Unutilized proceeds of ₹175.66 crore are in fixed deposits. The utilization timeline has been extended to November 15, 2027.
Read the summary - High impact
Artemis Medicare Q1 FY27: Revenue Up 12.7%, PAT Soars 48.3%
Artemis Medicare Services Ltd. reported Q1 FY27 consolidated revenue growth of 12.7% to ₹28,732 Lacs. PAT surged 48.3% to ₹3,144 Lacs, and EBITDA rose 27.9% to ₹6,182 Lacs. The company also commenced operations at its Raipur hospital in July 2026, marking a significant expansion step.
Read the summary - High impact
Artemis Medicare Q1FY27: Revenue up 15.4% to ₹27,849 Lacs, PAT surges 32.7%
Artemis Medicare reported Q1 FY27 results with Revenue up 15.4% YoY to ₹27,849 Lacs. EBITDA grew 24.4% YoY to ₹6,163 Lacs, and PAT rose 32.7% YoY to ₹3,306 Lacs. Consolidated PAT surged 48.3% YoY to ₹3,144 Lacs. The company is expanding capacity, aiming for ~2,000 beds in 3-5 years.
Read the summary - Medium impact
Artemis Medicare to add 200+ beds in Gurugram, invest ₹160-180 Cr.
Artemis Medicare Services Limited will add over 200 beds to its Gurugram hospital in Tower IV. The expansion, costing ₹160-180 Crore, is expected within two years. This aims to boost quaternary pediatric and women's health services. The company also announced its Q1 FY27 financial results.
Read the summary - High impact
Artemis Medicare Q1 FY27 Results: Profit Up, Approves ₹160-180 Cr Expansion
Artemis Medicare reported Q1 FY27 results with standalone profit after tax at ₹310.51 crore and consolidated profit after tax at ₹314.43 crore. The company approved a ₹160-180 crore expansion for Tower IV at its Gurugram hospital, adding over 200 beds for specialized pediatric and women's health services. The expansion is expected within two years.
Read the summary - Low impact
Artemis Medicare Services: Independent Director Mr. Sanjib Sen Completes Tenure
Mr. Sanjib Sen has ceased to be an Independent Director at Artemis Medicare Services Limited on August 2, 2026, upon completion of his tenure. The company has filed the necessary disclosures.
Read the summary - Low impact
Artemis Medicare Services Limited Re-appoints T R Chadha & Co LLP as Statutory Auditors
Artemis Medicare Services Limited has re-appointed M/s. T R Chadha & Co LLP as Statutory Auditors for a five-year term. The approval was granted at the 22nd AGM held on July 31, 2026. The firm will serve until the 27th AGM in 2031.
Read the summary - Medium impact
Artemis Medicare Appoints Dr. Girdhar Gyani as Independent Director
Artemis Medicare Services Limited appointed Dr. Girdhar Jessaram Gyani as an Independent Director for a three-year term starting August 1, 2026. The appointment was approved at the 22nd AGM held on July 31, 2026. Dr. Gyani brings extensive experience from roles at AHPI and the Quality Council of India.
Read the summary - Medium impact
Artemis Medicare Services Ltd. 22nd AGM: All resolutions passed, dividend declared.
Artemis Medicare Services Limited's 22nd AGM on July 31, 2026, passed all resolutions. Key approvals include audited financial statements for FY26, a final dividend of ₹0.45 per share, re-appointment of statutory auditors, and appointment of two independent directors. Remuneration for cost auditors and non-executive directors was also approved.
Read the summary - Medium impact
Artemis Medicare Services Holds 22nd AGM; Approves Dividend & Director Re-appointments
Artemis Medicare Services Limited held its 22nd AGM on July 31, 2026. Shareholders approved the financial statements for FY26 and declared a dividend of Re. 0.45 per share. Ms. Shalini Kanwar Chand was re-appointed as Director. M/s. T R Chadha & Co LLP re-appointed as Statutory Auditors. Mr. Tapan Mitra and Dr. Girdhar Gyani appointed as Independent Directors.
Read the summary - Low impact
Artemis Medicare Services Limited Schedules Q1 FY27 Earnings Conference Call for Aug 4
Artemis Medicare Services Limited will hold an Earnings Conference Call on August 4, 2026, at 11:00 AM IST to discuss Q1 FY27 performance. Key management and Anand Rathi Research will participate.
Read the summary - Medium impact
Artemis Medicare Services Ltd.: Special Resolution to Raise Funds Approved by Shareholders
Artemis Medicare Services Limited shareholders approved a special resolution to raise funds via equity issuance. The postal ballot, with remote e-voting from June 19 to July 18, 2026, saw strong support, with 98.68% voting in favor.
Read the summary - Low impact
Artemis Medicare Services: Public Notice for Special Window for Securities
Artemis Medicare Services Limited announces a one-year special window from February 5, 2026, to February 4, 2027, for transferring and dematerialising physical securities. This facility is for transfer deeds executed before April 1, 2019, that faced issues. Securities transferred will have a one-year lock-in.
Read the summary - Medium impact
Artemis Medicare Commences Operations at 300-Bed Raipur Hospital
Artemis Medicare Services Limited has commenced operations at its new 300-bed Artemis Shanti Hospital in Raipur, Chhattisgarh, effective July 9, 2026. This multi-specialty tertiary care facility aims to improve access to advanced medical services in Central India.
Read the summary - Low impact
Artemis Medicare Services Announces 22nd AGM & e-Voting Information
Artemis Medicare Services Limited announced its 22nd Annual General Meeting (AGM) and e-Voting details. Annual Report for FY26 and AGM notice sent to shareholders on July 7, 2026. Newspaper advertisements published on July 8, 2026.
Read the summary - Low impact
Artemis Medicare Services Files SEBI Depositories Compliance Certificate for Q1FY27
Artemis Medicare Services Limited filed its SEBI compliance certificate for the quarter ended June 30, 2026. The certificate confirms the dematerialization of equity shares and adherence to SEBI (Depositories and Participants) Regulations, 2018. This is a routine regulatory filing.
Read the summary - Low impact
Artemis Medicare Services Reminds Physical Security Holders to Update KYC Details
Artemis Medicare Services Limited is reminding physical security holders to submit KYC details, including PAN, contact, bank, and signature information, by SEBI's mandate. Failure to comply will restrict grievance lodging and service requests from the RTA. Payments will be processed electronically from April 1, 2024, post-KYC submission.
Read the summary - Low impact
Artemis Medicare Services: Trading Window Closed July 1, 2026, for Q1 FY27 Results
Artemis Medicare Services Limited will close its trading window from July 1, 2026. The window will reopen 48 hours after the declaration of financial results for the quarter ending June 30, 2026, in compliance with SEBI regulations.
Read the summary - Low impact
Artemis Medicare Services recommends ₹0.45 dividend; TDS details for FY25-26 announced
Artemis Medicare Services recommended a final dividend of ₹0.45 per equity share for FY 2025-26. The record date is July 10, 2026. Shareholders must provide updated tax-related documents by July 15, 2026, to determine TDS rates. Non-residents can avail DTAA benefits with proper documentation.
Read the summary - Low impact
Artemis Medicare Publishes AGM, E-Voting, and Dividend Notice in Newspapers
Artemis Medicare Services Limited has published a notice for its 22nd Annual General Meeting (AGM), including details on e-voting and dividend. The notice appeared in The Financial Express and The Jansatta on June 23, 2026.
Read the summary - Medium impact
Artemis Medicare Services Announces AGM on July 31, 2026, with Dividend Record Date July 10
Artemis Medicare Services Limited will hold its 22nd AGM on July 31, 2026. The record date for the proposed Final Dividend of Re. 0.45 per share (45%) for FY 2025-26 is July 10, 2026. E-voting will be open from July 28 to July 30, 2026.
Read the summary - Low impact
Artemis Medicare Services Announces AGM on July 31, 2026, with Dividend Record Date July 10
Artemis Medicare Services will hold its 22nd AGM on July 31, 2026, for the FY 2025-26. The company has fixed July 10, 2026, as the record date for a proposed final dividend of Re. 0.45 per equity share (45%). Remote e-voting will be open from July 28 to July 30, 2026.
Read the summary - Low impact
Artemis Medicare Services Ltd. Publishes Postal Ballot Notice in Newspapers
Artemis Medicare Services Limited published its Notice of Postal Ballot on June 19, 2026, in The Financial Express and The Jansatta newspapers. This action complies with SEBI Listing Regulations.
Read the summary - Medium impact
Artemis Medicare seeks shareholder approval for ₹700 Crore fundraising via equity issuance.
Artemis Medicare Services Limited is seeking shareholder approval to raise up to ₹700 Crore through the issuance of Equity Shares and/or other eligible securities. The fundraising aims to be conducted in one or more tranches via methods like preferential issues or QIP. Shareholder voting will occur through remote e-voting from June 19 to July 18, 2026.
Read the summary - Low impact
Artemis Medicare to host Investors/Analysts for Hospital Visit in Gurugram on June 19, 2026
Artemis Medicare Services Limited will host a hospital visit for investors and analysts in Gurugram on June 19, 2026. The interaction will be physical, and no Unpublished Price Sensitive Information will be shared.
Read the summary - Medium impact
Artemis Medicare Services to Raise ₹700 Crore via Equity Issuance
Artemis Medicare Services Limited's Board approved raising up to ₹700 crore through equity issuance. Shareholders' approval will be sought via postal ballot. The meeting concluded on June 4, 2026.
Read the summary - High impact
Artemis Medicare Q4 FY26 Earnings Call Transcript Released
Artemis Medicare reported FY26 consolidated revenue of ₹1,081 crore (up 15.4%) and PAT of ₹104 crore (up 26.2%). Q4 FY26 revenue grew 16.4% to ₹279 crore, with PAT up 32.1% to ₹30 crore. The company plans to expand bed capacity to 2,000 by 2029, with a new 300-bed hospital in Raipur opening in Q1 FY27 and a 650-bed facility in South Delhi by FY29. Fundraising of up to ₹700 crore is approved.
Read the summary - Low impact
Artemis Medicare Services Ltd. Announces Newspaper Publication for Special Window
Artemis Medicare Services Limited published a notice on May 15, 2026, in The Financial Express and The Jansatta regarding a Special Window for transfer and dematerialisation of physical securities. This is a compliance filing under SEBI regulations.
Read the summary - Low impact
Artemis Medicare Q4 & FY26 Earnings Conference Call Audio Recording Available
Artemis Medicare Services Limited released the audio recording of its Q4 and FY26 earnings conference call held on May 11, 2026. The recording discusses the company's operational and financial performance and is available on their website.
Read the summary - Low impact
Artemis Medicare Services: Independent Director Sunil Tandon Completes Tenure
Mr. Sunil Tandon has ceased to be an Independent Director at Artemis Medicare Services Limited upon completion of his tenure on May 9, 2026. The company has formally notified regulatory bodies about this change.
Read the summary - Low impact
Artemis Medicare Services Audited Financial Results Published on May 9, 2026
Artemis Medicare Services Limited published its audited financial results for the quarter and year ended March 31, 2026, on May 9, 2026. The results are available in The Financial Express and The Jansatta, as well as on the company's investor website.
Read the summary - Low impact
Artemis Medicare Services: Monitoring Agency Report for Q4FY26
Artemis Medicare Services Limited filed its Monitoring Agency Report for Q4FY26. The report covers the utilization of ₹330 crore from a Preferential Issue. During the quarter, ₹474.62 crore was utilized, including ₹54 crore for expansion and ₹74.62 crore as an advance revenue share. ₹193.11 crore remains unutilized.
Read the summary - Low impact
Artemis Medicare Services amends Fair Disclosure Code on May 8, 2026
Artemis Medicare Services Limited amended its Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information on May 8, 2026. The updated code ensures timely and uniform disclosure of price-sensitive information to stakeholders.
Read the summary - Medium impact
Artemis Medicare Services approves FY26 results, recommends Re. 0.45 dividend, appoints directors
Artemis Medicare Services reported audited financial results for the quarter and year ended March 31, 2026. The company recommended a final dividend of Re. 0.45 per share. Mr. Tapan Mitra was appointed as an Independent Director, effective May 8, 2026. Shareholder approval will be sought for Dr. Girdhar J. Gyani's appointment and the re-appointment of auditors.
Read the summary - High impact
Artemis Medicare Q4 FY26: Revenue Up 16.4%, PAT Up 32.1%
Artemis Medicare Services Ltd. reported a 16.4% YoY increase in consolidated revenue to ₹27,923 Lacs for Q4 FY26. PAT surged 32.1% to ₹3,028 Lacs. For FY26, consolidated revenue grew 15.4% to ₹1,08,124 Lacs, with PAT up 26.2% to ₹10,372 Lacs. The company is also progressing on its upcoming Raipur facility.
Read the summary - High impact
Artemis Medicare Q4 FY26 Revenue Up 16.4% to ₹279 Cr, PAT Jumps 32.1%
Artemis Medicare reported Q4 FY26 consolidated revenue of ₹279 Cr (up 16.4% YoY) and PAT of ₹30 Cr (up 32.1% YoY). FY26 consolidated revenue was ₹1,081 Cr (up 15.4% YoY) with PAT at ₹104 Cr (up 26.2% YoY). The company plans to expand capacity to 1,000 beds in Gurugram and is developing new hospitals in South Delhi and Raipur, with Raipur expected by May/June 2026. It also plans to raise ₹700 crore.
Read the summary - Medium impact
Artemis Medicare Services Announces Final Dividend, Board Appointments, and FY26 Results
Artemis Medicare Services recommended a final dividend of ₹0.45 per share for FY26. The company approved its audited financial results for Q4FY26 and the full year. Mr. Tapan Mitra was appointed as an Independent Director, effective May 8, 2026, and Dr. Girdhar J. Gyani's appointment is proposed for August 1, 2026. M/s. T R Chadha & Co LLP was re-appointed as statutory auditors.
Read the summary - Low impact
Artemis Medicare Schedules Q4 & FY26 Earnings Conference Call for May 11
Artemis Medicare Services Limited will hold an Earnings Conference Call on May 11, 2026, at 11:00 AM IST to discuss Q4 and FY26 performance. Key management, including the MD and CFO, will participate. Anand Rathi Research will host the event.
Read the summary - Low impact
Artemis Medicare Services Files SEBI Compliance Certificate for Q4FY26
Artemis Medicare Services Limited has submitted its SEBI compliance certificate for the quarter ending March 31, 2026. The filing confirms the dematerialization of physical share certificates and their listing on stock exchanges. This is a routine regulatory submission.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio